PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.\', \'Department of Medical Oncology, St George Hospital, Kogarah, New South Wales, Australia.\', \'St George and Sutherland Clinical Schools, University of New South Wales, Kogarah, New South Wales, Australia.\', \'Autonomous University of Barcelona, Barcelona, Spain.\', \'Department of Haematology, St George Hospital, Kogarah, New South Wales, Australia.\', \'Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.\', \'British Columbia Cancer Agency, Surrey, British Columbia, Canada.\', \'University of Toronto, Toronto, Ontario, Canada.\', \'University Health Network, Toronto, Ontario, Canada.\', \'Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada amit.oza@uhn.ca.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2020-047076
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 34301656
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
?:title
  • Ethical frameworks in clinical research processes during COVID-19: a scoping review.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34301656>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34301656>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all